Literature DB >> 23147757

Transplantation: An end to bone disease after renal transplantation?

Vincent M Brandenburg1, Jürgen Floege.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23147757     DOI： 10.1038/nrneph.2012.245

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Treatment with vitamin D and calcium reduces bone loss after renal transplantation: a randomized study.

Authors:  Ruud G L De Sévaux; Andries J Hoitsma; Frans H M Corstens; Jack F M Wetzels
Journal:  J Am Soc Nephrol       Date:  2002-06       Impact factor: 10.121

Review 2.  Management of mineral and bone disorder after kidney transplantation.

Authors:  Kamyar Kalantar-Zadeh; Miklos Z Molnar; Csaba P Kovesdy; Istvan Mucsi; Suphamai Bunnapradist
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-07       Impact factor: 2.894

3.  Effect of ibandronate on bone loss and renal function after kidney transplantation.

Authors:  Wolfgang Grotz; Christian Nagel; Daria Poeschel; Markus Cybulla; Karl-Georg Petersen; Markus Uhl; Christoph Strey; Günter Kirste; Manfred Olschewski; Achim Reichelt; Lars Christian Rump
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

4.  Individualized therapy to prevent bone mineral density loss after kidney and kidney-pancreas transplantation.

Authors:  Rahul Mainra; Grahame J Elder
Journal:  Clin J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 8.237

Review 5.  The fate of bone after renal transplantation.

Authors:  Vincent M Brandenburg; Ralf Westenfeld; Markus Ketteler
Journal:  J Nephrol       Date:  2004 Mar-Apr       Impact factor: 3.902

6.  Rapid loss of vertebral mineral density after renal transplantation.

Authors:  B A Julian; D A Laskow; J Dubovsky; E V Dubovsky; J J Curtis; L D Quarles
Journal:  N Engl J Med       Date:  1991-08-22       Impact factor: 91.245

7.  KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

Authors: 
Journal:  Kidney Int Suppl       Date:  2009-08       Impact factor: 10.545

8.  A 1-year randomized, double-blind, placebo-controlled study of intravenous ibandronate on bone loss following renal transplantation.

Authors:  K T Smerud; S Dolgos; I C Olsen; A Åsberg; S Sagedal; A V Reisæter; K Midtvedt; P Pfeffer; T Ueland; K Godang; J Bollerslev; A Hartmann
Journal:  Am J Transplant       Date:  2012-09-04       Impact factor: 8.086

9.  Effect of risedronate on bone in renal transplant recipients.

Authors:  Maria Coco; James Pullman; Hillel W Cohen; Sally Lee; Craig Shapiro; Clemencia Solorzano; Stuart Greenstein; Daniel Glicklich
Journal:  J Am Soc Nephrol       Date:  2012-07-12       Impact factor: 10.121

Review 10.  Interventions for preventing bone disease in kidney transplant recipients.

Authors:  S C Palmer; D O McGregor; G F Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18
  10 in total
  2 in total

Review 1.  Bone and mineral disorders after kidney transplantation: therapeutic strategies.

Authors:  Miklos Z Molnar; Mohamed S Naser; Connie M Rhee; Kamyar Kalantar-Zadeh; Suphamai Bunnapradist
Journal:  Transplant Rev (Orlando)       Date:  2013-12-12       Impact factor: 3.943

2.  Parathyroidectomy versus cinacalcet in the treatment of tertiary hyperparathyroidism after kidney transplantation: a retrospective study.

Authors:  Suyun Jung; Hyosang Kim; Hyunwook Kwon; Sung Shin; Young Hoon Kim; Won Woong Kim; Tae-Yon Sung; Yu-Mi Lee; Ki-Wook Chung; Su-Kil Park; Chung Hee Baek
Journal:  Kidney Res Clin Pract       Date:  2022-02-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.